Article
Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users.
Journal of gastroenterology and hepatology - 1 Sept 2007
Grebely Jason, Raffa Jesse D, Meagher Caite, Duncan Fiona, Genoway Krista A, Khara Milan, McLean Mark, Mead Annabel, Viljoen Mark, DeVlaming Stanley, Fraser Chris, Conway Brian
Abstract excerpt
BACKGROUND AND AIM: There are few studies investigating the treatment of hepatitis C virus (HCV) infection in current and former drug users. With this in mind, we sought to evaluate the antiviral efficacy of interferon alpha-2b (IFN alpha-2b) or pegylated-interferon alpha-2b (PEG-IFN alpha-2b) and ribavirin (RBV) in injection drug users (IDU) enrolled in a directly observed therapy (DOT) program, as measured by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
